Doxazosin

Common brands: Cardura, Cardura Xl, Katerzia, Norliqva, Sdamlo

Top reporter: Roerig

Dihydropyridine Calcium Channel Blocker [EPC]Nonsteroidal Anti-inflammatory Drug [EPC]Loop Diuretic [EPC]Calcium Channel Blocker [EPC]Proton Pump Inhibitor [EPC]
27,471
Total Reports
8,816
Serious Reports
2,291
Death Reports
30
Reported Reactions
Death Report Ratio: High (8.34%)

Patient Demographics

Male
16,413
Female
8,851

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Doxazosin.

# Reaction Reports % of Total
1 DYSPNOEA 1,494
5.8%
2 DIZZINESS 1,310
5.1%
3 FATIGUE 1,292
5.0%
4 DRUG INEFFECTIVE 1,266
4.9%
5 DIARRHOEA 1,253
4.9%
6 NAUSEA 1,160
4.5%
7 ACUTE KIDNEY INJURY 1,153
4.5%
8 HYPOTENSION 994
3.9%
9 HEADACHE 956
3.7%
10 ASTHENIA 954
3.7%
11 HYPERTENSION 881
3.4%
12 DRUG INTERACTION 869
3.4%
13 VOMITING 847
3.3%
14 OFF LABEL USE 803
3.1%
15 RENAL FAILURE 779
3.0%
16 MALAISE 777
3.0%
17 FALL 752
2.9%
18 PAIN 723
2.8%
19 ARTHRALGIA 719
2.8%
20 SYNCOPE 693
2.7%
21 DEATH 685
2.7%
22 CHRONIC KIDNEY DISEASE 664
2.6%
23 ANAEMIA 636
2.5%
24 PNEUMONIA 627
2.4%
25 CONFUSIONAL STATE 584
2.3%
26 PAIN IN EXTREMITY 583
2.3%
27 CONDITION AGGRAVATED 576
2.2%
28 ANXIETY 572
2.2%
29 BLOOD PRESSURE INCREASED 557
2.2%
30 RASH 550
2.1%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.